Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200207766> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W4200207766 endingPage "S386" @default.
- W4200207766 startingPage "S385" @default.
- W4200207766 abstract "This study aimed to explore the association between medication-associated anticholinergic burden and cognitive and daily living functions in patients with schizophrenia.Sixty patients with schizophrenia were recruited. We used the Anticholinergic Drug Scale (ADS) for evaluating medication-associated anticholinergic burden. The MATRICS Consensus Cognitive Battery (MCCB) and the University of California San Diego Performance-based Skills Assessment (UPSA) were used for evaluating cognitive and daily living functions. To assess clinical symptoms, psychiatrists conducted interviews using the Positive and Negative Syndrome Scale and the Calgary Depression Scale for Schizophrenia.Subjects were divided into low (n = 31) and high (n = 29) anticholinergic burden based on ADS scores of 3 or more. The “high ADS” group had poorer cognitive (composite MCCB score, p < 0.001) and daily living functions (total UPSA score, p = 0.001) than the “low ADS” group. Medication-associated anticholinergic burden was negatively correlated with cognitive functions (composite MCCB score, r = −0.512, p < 0.001) and daily living functions (total UPSA score, r = −0.355, p = 0.005). A regression analysis showed that anticholinergic burden significantly explained the decline in cognitive functions (composite MCCB score, R2 = 0.262, p < 0.001) and daily living functions (total UPSA score, R2 = 0.126, p = 0.005). Explanatory power was reduced after a covariate adjustment, but the effects of the composite MCCB score (p = 0.013) and of the transportation domain score of the UPSA (p = 0.048) remained significant.Our analysis shows that anticholinergic burden reduces cognitive and daily living functions in patients with schizophrenia. A drug strategy with minimal anticholinergic burden may be helpful to patients if it does not adversely affect clinical symptoms." @default.
- W4200207766 created "2021-12-31" @default.
- W4200207766 creator A5014164411 @default.
- W4200207766 creator A5035416699 @default.
- W4200207766 creator A5062205961 @default.
- W4200207766 date "2021-12-01" @default.
- W4200207766 modified "2023-09-23" @default.
- W4200207766 title "P.0522 Accessing electroconvulsive therapy: description and factors associated with variation of utilization in france in 2019" @default.
- W4200207766 cites W2182104458 @default.
- W4200207766 cites W2398163015 @default.
- W4200207766 cites W2478698564 @default.
- W4200207766 cites W2623029168 @default.
- W4200207766 doi "https://doi.org/10.1016/j.euroneuro.2021.10.494" @default.
- W4200207766 hasPublicationYear "2021" @default.
- W4200207766 type Work @default.
- W4200207766 citedByCount "0" @default.
- W4200207766 crossrefType "journal-article" @default.
- W4200207766 hasAuthorship W4200207766A5014164411 @default.
- W4200207766 hasAuthorship W4200207766A5035416699 @default.
- W4200207766 hasAuthorship W4200207766A5062205961 @default.
- W4200207766 hasConcept C118552586 @default.
- W4200207766 hasConcept C126322002 @default.
- W4200207766 hasConcept C15744967 @default.
- W4200207766 hasConcept C169900460 @default.
- W4200207766 hasConcept C185711340 @default.
- W4200207766 hasConcept C2776412080 @default.
- W4200207766 hasConcept C2778689640 @default.
- W4200207766 hasConcept C2779727114 @default.
- W4200207766 hasConcept C2780135775 @default.
- W4200207766 hasConcept C70410870 @default.
- W4200207766 hasConcept C71924100 @default.
- W4200207766 hasConcept C79544238 @default.
- W4200207766 hasConceptScore W4200207766C118552586 @default.
- W4200207766 hasConceptScore W4200207766C126322002 @default.
- W4200207766 hasConceptScore W4200207766C15744967 @default.
- W4200207766 hasConceptScore W4200207766C169900460 @default.
- W4200207766 hasConceptScore W4200207766C185711340 @default.
- W4200207766 hasConceptScore W4200207766C2776412080 @default.
- W4200207766 hasConceptScore W4200207766C2778689640 @default.
- W4200207766 hasConceptScore W4200207766C2779727114 @default.
- W4200207766 hasConceptScore W4200207766C2780135775 @default.
- W4200207766 hasConceptScore W4200207766C70410870 @default.
- W4200207766 hasConceptScore W4200207766C71924100 @default.
- W4200207766 hasConceptScore W4200207766C79544238 @default.
- W4200207766 hasLocation W42002077661 @default.
- W4200207766 hasOpenAccess W4200207766 @default.
- W4200207766 hasPrimaryLocation W42002077661 @default.
- W4200207766 hasRelatedWork W1980472391 @default.
- W4200207766 hasRelatedWork W2001166226 @default.
- W4200207766 hasRelatedWork W2044979734 @default.
- W4200207766 hasRelatedWork W2076311285 @default.
- W4200207766 hasRelatedWork W2104192231 @default.
- W4200207766 hasRelatedWork W2123500323 @default.
- W4200207766 hasRelatedWork W2323006566 @default.
- W4200207766 hasRelatedWork W2888946266 @default.
- W4200207766 hasRelatedWork W2980115982 @default.
- W4200207766 hasRelatedWork W4285269129 @default.
- W4200207766 hasVolume "53" @default.
- W4200207766 isParatext "false" @default.
- W4200207766 isRetracted "false" @default.
- W4200207766 workType "article" @default.